Genomic promoter occupancy of Runt-related transcription factor RUNX2 in osteosarcoma cells identifies genes involved in cell adhesion and motility

Journal of Biological Chemistry

Volumn 287, Issue 7, 2012, Pages 4503-4517

  Van Der Deen, Margaretha ^a   Akech, Jacqueline ^a   Lapointe, David ^a   Gupta, Sneha ^a   Young, Daniel W ^a   Montecino, Martin A ^b   Galindo, Mario ^c   Lian, Jane B ^a   Stein, Janet L ^a   Stein, Gary S ^a   Van Wijnen, Andre J ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSIDAD ANDRÉS BELLO   (Chile)

^c UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL FUNCTIONS; BIOLOGICAL PROPERTIES; BONE FORMATION; CANCER GENES; CELL MOTILITY; CHROMATIN IMMUNOPRECIPITATION; CONSENSUS MOTIF; GENE EXPRESSION PROFILES; GENE ONTOLOGY; MICROARRAY ANALYSIS; OSTEOSARCOMA CELLS; PROGENITOR CELL; PROSTATE TUMOR; RNA INTERFERENCE; RNA POLYMERASE II; SAOS-2 CELLS; SIGNALING PATHWAYS; TUMORIGENESIS;

ADHESION; CELL ADHESION; CELLS; RNA; TRANSCRIPTION FACTORS; UROLOGY;

GENES;

TRANSCRIPTION FACTOR RUNX2;

ARTICLE; BIOLOGICAL ACTIVITY; CARCINOGENESIS; CELL ADHESION; CELL MOTILITY; CHROMATIN IMMUNOPRECIPITATION; CONSENSUS SEQUENCE; CONTROLLED STUDY; DNA MICROARRAY; GENE ACTIVITY; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE INTERACTION; GENE LOCUS; GENOME ANALYSIS; HUMAN; HUMAN CELL; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

BONE NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CHROMATIN IMMUNOPRECIPITATION; CORE BINDING FACTOR ALPHA 1 SUBUNIT; GENETIC LOCI; GENOME, HUMAN; HUMANS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOSARCOMA; RESPONSE ELEMENTS; RNA POLYMERASE II;

EID: 84863139254     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.287771     Document Type: Article

References (79)

1. Wang, C. Q., Jacob, B., Nah, G. S., and Osato, M. (2010) Runx family genes, niche, and stem cell quiescence. Blood Cells Mol. Dis. 44, 275-286
2. Niebuhr, B., Fischer, M., Täger, M., Cammenga, J., and Stocking, C. (2008) Gatekeeper function of theRUNX1transcription factor in acute leukemia. Blood Cells Mol. Dis. 40, 211-218 (Pubitemid 351221378)
3. Lian, J. B., Stein, G. S., Javed, A., van Wijnen, A. J., Stein, J. L., Montecino, M., Hassan, M. Q., Gaur, T., Lengner, C. J., and Young, D. W. (2006) Networks and hubs for the transcriptional control of osteoblastogenesis. Rev. Endocr. Metab. Disord. 7, 1-16 (Pubitemid 46044345)
4. Chuang, L. S., and Ito, Y. (2010) RUNX3 is multifunctional in carcinogenesis of multiple solid tumors. Oncogene 29, 2605-2615
5. Subramaniam, M. M., Chan, J. Y., Yeoh, K. G., Quek, T., Ito, K., and Salto-Tellez, M. (2009) Molecular pathology of RUNX3 in human carcinogenesis. Biochim. Biophys. Acta 1796, 315-331
6. Kilbey, A., Terry, A., Cameron, E. R., and Neil, J. C. (2008) Oncogeneinduced senescence. An essential role for Runx. Cell Cycle 7, 2333-2340
7. Pratap, J., Lian, J. B., Javed, A., Barnes, G. L., van Wijnen, A. J., Stein, J. L., and Stein, G. S. (2006) Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone. Cancer Metastasis Rev. 25, 589-600 (Pubitemid 46071865)
8. Blyth, K., Cameron, E. R., and Neil, J. C. (2005) The RUNX genes. Gain or loss of function in cancer. Nat. Rev. Cancer 5, 376-387 (Pubitemid 40637829)
9. Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., and Downing, J. R. (1996) AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84, 321-330 (Pubitemid 26042836)
10. Wang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A. H., and Speck, N. A. (1996) Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci. U.S.A. 93, 3444-3449 (Pubitemid 26125639)
11. Dowdy, C. R., Xie, R., Frederick, D., Hussain, S., Zaidi, S. K., Vradii, D., Javed, A., Li, X., Jones, S. N., Lian, J. B., van Wijnen, A. J., Stein, J. L., and Stein, G. S. (2010) Definitive hematopoiesis requires Runx1 C-terminal mediated subnuclear targeting and transactivation. Hum. Mol. Genet. 19, 1048-1057
12. Li, Q. L., Ito, K., Sakakura, C., Fukamachi, H., Inoue, K., Chi, X. Z., Lee, K. Y., Nomura, S., Lee, C. W., Han, S. B., Kim, H. M., Kim, W. J., Yamamoto, H., Yamashita, N., Yano, T., Ikeda, T., Itohara, S., Inazawa, J., Abe, T., Hagiwara, A., Yamagishi, H., Ooe, A., Kaneda, A., Sugimura, T., Ushijima, T., Bae, S. C., and Ito, Y. (2002) Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109, 113-124 (Pubitemid 34327521)
13. Inoue, K., Ozaki, S., Shiga, T., Ito, K., Masuda, T., Okado, N., Iseda, T., Kawaguchi, S., Ogawa, M., Bae, S. C., Yamashita, N., Itohara, S., Kudo, N., and Ito, Y. (2002) Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons. Nat. Neurosci. 5, 946-954
14. Woolf, E., Xiao, C., Fainaru, O., Lotem, J., Rosen, D., Negreanu, V., Bernstein, Y., Goldenberg, D., Brenner, O., Berke, G., Levanon, D., and Groner, Y. (2003) Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis. Proc. Natl. Acad. Sci. U.S.A. 100, 7731-7736 (Pubitemid 36760038)
15. Stewart, M., Terry, A., O'Hara, M., Cameron, E., Onions, D., and Neil, J. C. (1996) til-1.Anovel proviral insertion locus for Moloney murine leukemia virus in lymphomas of CD2-myc transgenic mice. J. Gen. Virol. 77, 443-446
16. Stewart, M., Terry, A., Hu, M., O'Hara, M., Blyth, K., Baxter, E., Cameron, E., Onions, D. E., and Neil, J. C. (1997) Proviral insertions induce the expression of bone-specific isoforms of PEBP2αA(CBFA1). Evidence for a new myc collaborating oncogene. Proc. Natl. Acad. Sci. U.S.A. 94, 8646-8651 (Pubitemid 27335093)
17. Vaillant, F., Blyth, K., Andrew, L., Neil, J. C., and Cameron, E. R. (2002) Enforced expression of Runx2 perturbs T cell development at a stage coincident with β-selection. J. Immunol. 169, 2866-2874 (Pubitemid 35013127)
18. Blyth, K., Vaillant, F., Hanlon, L., Mackay, N., Bell, M., Jenkins, A., Neil, J. C., and Cameron, E. R. (2006) Runx2 and MY Ccollaborate in lymphoma development by suppressing apoptotic and growth arrest pathways in vivo. Cancer Res. 66, 2195-2201
19. Mundlos, S., Otto, F., Mundlos, C., Mulliken, J. B., Aylsworth, A. S., Albright, S., Lindhout, D., Cole, W. G., Henn, W., Knoll, J. H., Owen, M. J., Mertelsmann, R., Zabel, B. U., and Olsen, B. R. (1997) Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89, 773-779 (Pubitemid 27516180)
20. Ott, C. E., Leschik, G., Trotier, F., Brueton, L., Brunner, H. G., Brussel, W., Guillen-Navarro, E., Haase, C., Kohlhase, J., Kotzot, D., Lane, A., Lee- Kirsch, M. A., Morlot, S., Simon, M. E., Steichen-Gersdorf, E., Tegay, D. H., Peters, H., Mundlos, S., and Klopocki, E. (2010) Deletions of the RUNX2 gene are present in about 10% of individuals with cleidocranial dysplasia. Hum. Mutat. 31, E1587-E1593
21. Han, M. S., Kim, H. J., Wee, H. J., Lim, K. E., Park, N. R., Bae, S. C., van Wijnen, A. J., Stein, J. L., Lian, J. B., Stein, G. S., and Choi, J. Y. (2010) The cleidocranial dysplasia-related R131G mutation in the Runt-related transcription factor RUNX2 disrupts binding to DNA but not CBF-β. J. Cell. Biochem. 110, 97-103
22. Kim, H. J., Nam, S. H., Kim, H. J., Park, H. S., Ryoo, H. M., Kim, S. Y., Cho, T. J., Kim, S. G., Bae, S. C., Kim, I. S., Stein, J. L., van Wijnen, A. J., Stein, G. S., Lian, J. B., and Choi, J. Y. (2006) Four novel RUNX2 mutations including a splice donor site result in the cleidocranial dysplasia phenotype. J. Cell. Physiol. 207, 114-122
23. Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R. T., Gao, Y. H., Inada, M., Sato, M., Okamoto, R., Kitamura, Y., Yoshiki, S., and Kishimoto, T. (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755-764 (Pubitemid 27516178)
24. Otto, F., Thornell, A. P., Crompton, T., Denzel, A., Gilmour, K. C., Rosewell, I. R., Stamp, G. W., Beddington, R. S., Mundlos, S., Olsen, B. R., Selby, P. B., and Owen, M. J. (1997) Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89, 765-771 (Pubitemid 27516179)
25. Choi, J. Y., Pratap, J., Javed, A., Zaidi, S. K., Xing, L., Balint, E., Dalamangas, S., Boyce, B., van Wijnen, A. J., Lian, J. B., Stein, J. L., Jones, S. N., and Stein, G. S. (2001) Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development. Proc. Natl. Acad. Sci. U.S.A. 98, 8650-8655 (Pubitemid 32678082)
26. Lou, Y., Javed, A., Hussain, S., Colby, J., Frederick, D., Pratap, J., Xie, R., Gaur, T., van Wijnen, A. J., Jones, S. N., Stein, G. S., Lian, J. B., and Stein, J. L. (2009) A Runx2 threshold for the cleidocranial dysplasia phenotype. Hum. Mol. Genet. 18, 556-568
27. Pratap, J., Galindo, M., Zaidi, S. K., Vradii, D., Bhat, B. M., Robinson, J. A., Choi, J. Y., Komori, T., Stein, J. L., Lian, J. B., Stein, G. S., and van Wijnen, A. J. (2003) Cell growth regulatory role of Runx2 during proliferative expansion of preosteoblasts. Cancer Res. 63, 5357-5362 (Pubitemid 37139851)
28. Galindo, M., Pratap, J., Young, D. W., Hovhannisyan, H., Im, H. J., Choi, J. Y., Lian, J. B., Stein, J. L., Stein, G. S., and van Wijnen, A. J. (2005) The bone-specific expression of Runx2 oscillates during the cell cycle to support a G1-related antiproliferative function in osteoblasts. J. Biol. Chem. 280, 20274-20285 (Pubitemid 40776725)
29. Young, D. W., Hassan, M. Q., Pratap, J., Galindo, M., Zaidi, S. K., Lee, S. H., Yang, X., Xie, R., Javed, A., Underwood, J. M., Furcinitti, P., Imbalzano, A. N., Penman, S., Nickerson, J. A., Montecino, M. A., Lian, J. B., Stein, J. L., van Wijnen, A. J., and Stein, G. S. (2007) Mitotic occupancy and lineagespecific transcriptional control of rRNA genes by Runx2. Nature 445, 442-446 (Pubitemid 46160913)
30. Zaidi, S. K., Pande, S., Pratap, J., Gaur, T., Grigoriu, S., Ali, S. A., Stein, J. L., Lian, J. B., van Wijnen, A. J., and Stein, G. S. (2007) Runx2 deficiency and defective subnuclear targeting bypass senescence to promote immortalization and tumorigenic potential. Proc. Natl. Acad. Sci. U.S.A. 104, 19861-19866
31. Teplyuk, N. M., Galindo, M., Teplyuk, V. I., Pratap, J., Young, D. W., Lapointe, D., Javed, A., Stein, J. L., Lian, J. B., Stein, G. S., and van Wijnen, A. J. (2008) Runx2 regulates G protein-coupled signaling pathways to control growth of osteoblast progenitors. J. Biol. Chem. 283, 27585-27597
32. Kilbey, A., Blyth, K., Wotton, S., Terry, A., Jenkins, A., Bell, M., Hanlon, L., Cameron, E. R., and Neil, J. C. (2007) Runx2 disruption promotes immortalization and confers resistance to oncogene-induced senescence in primary murine fibroblasts. Cancer Res. 67, 11263-11271 (Pubitemid 350248552)
33. Galindo, M., Kahler, R. A., Teplyuk, N. M., Stein, J. L., Lian, J. B., Stein, G. S., Westendorf, J. J., and van Wijnen, A. J. (2007) Cell cycle related modulations in Runx2 protein levels are independent of lymphocyte enhancer- binding factor 1 (Lef1) in proliferating osteoblasts. J. Mol. Histol. 38, 501-506 (Pubitemid 350056782)
34. San Martin, I. A., Varela, N., Gaete, M., Villegas, K., Osorio, M., Tapia, J. C., Antonelli, M., Mancilla, E. E., Pereira, B. P., Nathan, S. S., Lian, J. B., Stein, J. L., Stein, G. S., van Wijnen, A. J., and Galindo, M. (2009) Impaired cell cycle regulation of the osteoblast-related heterodimeric transcription factor Runx2-Cbfß in osteosarcoma cells. J. Cell. Physiol. 221, 560-571
35. Pereira, B. P., Zhou, Y., Gupta, A., Leong, D. T., Aung, K. Z., Ling, L., Pho, R. W., Galindo, M., Salto-Tellez, M., Stein, G. S., Cool, S. M., van Wijnen, A. J., and Nathan, S. S. (2009) Runx2, p53, and pRB status as diagnostic parameters for deregulation of osteoblast growth and differentiation in a new prechemotherapeutic osteosarcoma cell line (OS1). J. Cell. Physiol. 221, 778-788
36. Sadikovic, B., Thorner, P., Chilton-Macneill, S., Martin, J. W., Cervigne, N. K., Squire, J., and Zielenska, M. (2010) Expression analysis of genes associated with human osteosarcoma tumors shows correlation of RUNX2 overexpression with poor response to chemotherapy. BMC Cancer 10, 202
37. Martin, J. W., Yoshimoto, M., Ludkovski, O., Thorner, P. S., Zielenska, M., Squire, J. A., and Nuin, P. A. (2010) Analysis of segmental duplications, mouse genome synteny, and recurrent cancer-associated amplicons in human chromosome 6p21-p12. Cytogenet. Genome Res. 128, 199-213
38. Teplyuk, N. M., Zhang, Y., Lou, Y., Hawse, J. R., Hassan, M. Q., Teplyuk, V. I., Pratap, J., Galindo, M., Stein, J. L., Stein, G. S., Lian, J. B., and van Wijnen, A. J. (2009) The osteogenic transcription factor runx2 controls genes involved in sterol/steroid metabolism, including CYP11A1 in osteoblasts. Mol. Endocrinol. 23, 849-861
39. Jeong, J. H., Jung, Y. K., Kim, H. J., Jin, J. S., Kim, H. N., Kang, S. M., Kim, S. Y., van Wijnen, A. J., Stein, J. L., Lian, J. B., Stein, G. S., Kato, S., and Choi, J. Y. (2010) The gene for aromatase, a rate-limiting enzyme for local estrogen biosynthesis, is a downstream target gene of Runx2 in skeletal tissues. Mol. Cell. Biol. 30, 2365-2375
40. Young, D. W., Hassan, M. Q., Yang, X. Q., Galindo, M., Javed, A., Zaidi, S. K., Furcinitti, P., Lapointe, D., Montecino, M., Lian, J. B., Stein, J. L., van Wijnen, A. J., and Stein, G. S. (2007) Mitotic retention of gene expression patterns by the cell fate-determining transcription factor Runx2. Proc. Natl. Acad. Sci. U.S.A. 104, 3189-3194 (Pubitemid 46364135)
41. Westendorf, J. J., Zaidi, S. K., Cascino, J. E., Kahler, R., van Wijnen, A. J., Lian, J. B., Yoshida, M., Stein, G. S., and Li, X. (2002) Runx2 (Cbfa1, AML-3) interacts with histone deacetylase 6 and represses the p21(CIP1/ WAF1) promoter. Mol. Cell. Biol. 22, 7982-7992 (Pubitemid 35217306)
42. Jensen, E. D., Niu, L., Caretti, G., Nicol, S. M., Teplyuk, N., Stein, G. S., Sartorelli, V., van Wijnen, A. J., Fuller-Pace, F. V., and Westendorf, J. J. (2008) p68 (Ddx5) interacts with Runx2 and regulates osteoblast differentiation. J. Cell. Biochem. 103, 1438-1451 (Pubitemid 351490713)
43. Teplyuk, N. M., Haupt, L. M., Ling, L., Dombrowski, C., Mun, F. K., Nathan, S. S., Lian, J. B., Stein, J. L., Stein, G. S., Cool, S. M., and van Wijnen, A. J. (2009) The osteogenic transcription factor Runx2 regulates components of the fibroblast growth factor/proteoglycan signaling axis in osteoblasts. J. Cell. Biochem. 107, 144-154
44. Haupt, L. M., Murali, S., Mun, F. K., Teplyuk, N., Mei, L. F., Stein, G. S., van Wijnen, A. J., Nurcombe, V., and Cool, S. M. (2009) The heparan sulfate proteoglycan (HSPG) glypican-3 mediates commitment of MC3T3-E1 cells toward osteogenesis. J. Cell. Physiol. 220, 780-791
45. Akech, J., Wixted, J. J., Bedard, K., van der Deen, M., Hussain, S., Guise, T. A., van Wijnen, A. J., Stein, J. L., Languino, L. R., Altieri, D. C., Pratap, J., Keller, E., Stein, G. S., and Lian, J. B. (2010) Runx2 association with progression of prostate cancer in patients. Mechanisms mediating bone osteolysis and osteoblastic metastatic lesions. Oncogene 29, 811-821
46. Pratap, J., Imbalzano, K. M., Underwood, J. M., Cohet, N., Gokul, K., Akech, J., van Wijnen, A. J., Stein, J. L., Imbalzano, A. N., Nickerson, J. A., Lian, J. B., and Stein, G. S. (2009) Ectopic runx2 expression in mammary epithelial cells disrupts formation of normal acini structure. Implications for breast cancer progression. Cancer Res. 69, 6807-6814
47. Pratap, J., Wixted, J. J., Gaur, T., Zaidi, S. K., Dobson, J., Gokul, K. D., Hussain, S., van Wijnen, A. J., Stein, J. L., Stein, G. S., and Lian, J. B. (2008) Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells. Cancer Res. 68, 7795-7802
48. Baniwal, S. K., Khalid, O., Gabet, Y., Shah, R. R., Purcell, D. J., Mav, D., Kohn-Gabet, A. E., Shi, Y., Coetzee, G. A., and Frenkel, B. (2010) Runx2 transcriptome of prostate cancer cells. Insights into invasiveness and bone metastasis. Mol. Cancer 9, 258
49. Pregizer, S., Barski, A., Gersbach, C. A., García, A. J., and Frenkel, B. (2007) Identification of novel Runx2 targets in osteoblasts. Cell type-specific BMP-dependent regulation of Tram2. J. Cell. Biochem. 102, 1458-1471 (Pubitemid 350223948)
50. Thirunavukkarasu, K., Pei, Y., and Wei, T. (2007) Characterization of the human ADAMTS-5 (aggrecanase-2) gene promoter. Mol. Biol. Rep. 34, 225-231 (Pubitemid 47624284)
51. Thirunavukkarasu, K., Pei, Y., Moore, T. L., Wei, T., Wang, H., and Chandrasekhar, S. (2007) Regulation of NFATc2 gene expression by the transcription factor Runx2. Mol. Biol. Rep. 34, 1-10 (Pubitemid 46220351)
52. Kilbey, A., Terry, A., Jenkins, A., Borland, G., Zhang, Q., Wakelam, M. J., Cameron, E. R., and Neil, J. C. (2010) Runx regulation of sphingolipid metabolism and survival signaling. Cancer Res. 70, 5860-5869
53. Lee, T. I., Johnstone, S. E., and Young, R. A. (2006) Chromatin immunoprecipitation and microarray-based analysis of protein location. Nat. Protoc. 1, 729-748
54. van der Deen, M., Hassan, M. Q., Pratap, J., Teplyuk, N. M., Young, D. W., Javed, A., Zaidi, S. K., Lian, J. B., Montecino, M., Stein, J. L., Stein, G. S., and van Wijnen, A. J. (2008) Chromatin immunoprecipitation assays. Application of ChIP-on-chip for defining dynamic transcriptional mechanisms in bone cells. Methods Mol. Biol. 455, 165-176
55. O'Geen, H., Nicolet, C. M., Blahnik, K., Green, R., and Farnham, P. J. (2006) Comparison of sample preparation methods for ChIP-chip assays. BioTechniques 41, 577-580 (Pubitemid 46534868)
56. Drissi, H., Pouliot, A., Stein, J. L., van Wijnen, A. J., Stein, G. S., and Lian, J. B. (2002) Identification of novel protein/DNA interactions within the promoter of the bone-related transcription factor Runx2/Cbfa1. J. Cell. Biochem. 86, 403-412 (Pubitemid 34743395)
57. Frith, M. C., Fu, Y., Yu, L., Chen, J. F., Hansen, U., and Weng, Z. (2004) Detection of functional DNA motifs via statistical over-representation. Nucleic Acids Res. 32, 1372-1381 (Pubitemid 38854738)
58. McLeay, R. C., and Bailey, T. L. (2010) Motif enrichment analysis. A unified framework and an evaluation on ChIP data. BMC Bioinformatics 11, 165
59. Vlieghe, D., Sandelin, A., De Bleser, P. J., Vleminckx, K., Wasserman, W. W., van Roy, F., and Lenhard, B. (2006) A new generation of JASPAR, the open-access repository for transcription factor binding site profiles. Nucleic Acids Res. 34, D95-D97
60. Sandelin, A., Alkema, W., Engström, P., Wasserman, W. W., and Lenhard, B. (2004) JASPAR. An open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res. 32, D91-D94 (Pubitemid 38081611)
61. Knüppel, R., Dietze, P., Lehnberg, W., Frech, K., and Wingender, E. (1994) TRANSFAC retrieval program. A network model database of eukaryotic transcription regulating sequences and proteins. J. Comput. Biol. 1, 191-198
62. Li, C., and Wong, W. H. (2001) Model-based analysis of oligonucleotide arrays. Expression index computation and outlier detection. Proc. Natl. Acad. Sci. U.S.A. 98, 31-36 (Pubitemid 32095858)
63. Balint, E., Lapointe, D., Drissi, H., van der Meijden, C., Young, D. W., van Wijnen, A. J., Stein, J. L., Stein, G. S., and Lian, J. B. (2003) Phenotype discovery by gene expression profiling. Mapping of biological processes linked to BMP-2-mediated osteoblast differentiation. J. Cell. Biochem. 89, 401-426 (Pubitemid 36547274)
64. van der Meijden, C. M., Lapointe, D. S., Luong, M. X., Peric-Hupkes, D., Cho, B., Stein, J. L., van Wijnen, A. J., and Stein, G. S. (2002) Gene profiling of cell cycle progression through S-phase reveals sequential expression of genes required for DNA replication and nucleosome assembly. Cancer Res. 62, 3233-3243 (Pubitemid 34602419)
65. Ruijter, J. M., Ramakers, C., Hoogaars, W. M., Karlen, Y., Bakker, O., van den Hoff, M. J., and Moorman, A. F. (2009) Amplification efficiency. Linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res. 37, e45
66. Drissi, H., Luc, Q., Shakoori, R., Chuva De Sousa Lopes, S., Choi, J. Y., Terry, A., Hu, M., Jones, S., Neil, J. C., Lian, J. B., Stein, J. L., Van Wijnen, A. J., and Stein, G. S. (2000) Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene. J. Cell. Physiol. 184, 341-350 (Pubitemid 30625497)
67. Rodan, G. A., and Noda, M. (1991) Gene expression in osteoblastic cells. Crit. Rev. Eukaryot. Gene Expr. 1, 85-98
68. Meyers, S., Downing, J. R., and Hiebert, S. W. (1993) Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequencespecific DNA-binding proteins. The runt homology domain is required for DNA binding and protein-protein interactions. Mol. Cell. Biol. 13, 6336-6345 (Pubitemid 23292627)
69. Otto, F., Lübbert, M., and Stock, M. (2003) Upstream and downstream targets of RUNX proteins. J. Cell. Biochem. 89, 9-18 (Pubitemid 36459094)
70. Huang da W., Sherman, B. T., and Lempicki, R. A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57
71. Wang, C., Fu, M., Mani, S., Wadler, S., Senderowicz, A. M., and Pestell, R. G. (2001) Histone acetylation and the cell-cycle in cancer. Front Biosci. 6, D610-D629
72. Shattil, S. J., Kim, C., and Ginsberg, M. H. (2010) The final steps of integrin activation. The end game. Nat. Rev. Mol. Cell Biol. 11, 288-300
73. Moser, M., Legate, K. R., Zent, R., and Fässler, R. (2009) The tail of integrins, talin, and kindlins. Science 324, 895-899
74. Pratap, J., Javed, A., Languino, L. R., van Wijnen, A. J., Stein, J. L., Stein, G. S., and Lian, J. B. (2005) The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Mol. Cell. Biol. 25, 8581-8591 (Pubitemid 41369178)
75. Leong, D. T., Lim, J., Goh, X., Pratap, J., Pereira, B. P., Kwok, H. S., Nathan, S. S., Dobson, J. R., Lian, J. B., Ito, Y., Voorhoeve, P. M., Stein, G. S., Salto-Tellez, M., Cool, S. M., and van Wijnen, A. J. (2010) Cancer-related ectopic expression of the bone-related transcription factor RUNX2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility. Breast Cancer Res. 12, R89
76. Das, K., Leong, D. T., Gupta, A., Shen, L., Putti, T., Stein, G. S., van Wijnen, A. J., and Salto-Tellez, M. (2009) Positive association between nuclear Runx2 and estrogen-progesterone receptor gene expression characterizes a biological subtype of breast cancer. Eur. J. Cancer 45, 2239-2248
77. Pratap, J., Lian, J. B., and Stein, G. S. (2011) Metastatic bone disease. Role of transcription factors and future targets. Bone 48, 30-36
78. van der Deen, M., Akech, J., Wang, T., FitzGerald, T. J., Altieri, D. C., Languino, L. R., Lian, J. B., van Wijnen, A. J., Stein, J. L., and Stein, G. S. (2010) The cancer-related Runx2 protein enhances cell growth and responses to androgen and TGFβ in prostate cancer cells. J. Cell. Biochem. 109, 828-837
79. Farnham, P. J. (2009) Insights from genomic profiling of transcription factors. Nat. Rev. Genet. 10, 605-616